[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:retinal-specific-phospholipid-transporting-atpase-abca4":3},{"name":4,"total":5,"recruiting":6,"trials":7},"Retinal-Specific Phospholipid-Transporting ATPase ABCA4",11,8,[8,16,22,28,35,41,47,53,59,67,74],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06942572","A Phase 1\u002F2, First-in-Human Dose Escalation\u002FExpansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:19:19.975067Z","2026-05-05T02:43:29.391410Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06467344","Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)",[12],"2026-08-26T02:15:22.311223Z","2026-05-05T02:43:28.311573Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT07161544","A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)",[12],"2026-08-26T02:15:01.639696Z","2026-05-05T02:35:31.913516Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":33,"content_modified":34},"NCT07419334","Study of ALK-001 on the Progression of Stargardt Disease",[32],"Phase 3","2026-08-26T02:16:38.897933Z","2026-04-29T02:57:57.076637Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT07425574","A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults",[],"2026-08-26T02:16:01.910993Z","2026-07-19T19:36:05.078333Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT06445322","Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)",[],"2026-08-26T02:18:15.214990Z","2026-05-13T02:55:06.493722Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":51,"content_modified":52},"NCT06435000","An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene",[],"2026-08-26T02:18:51.009190Z","2026-05-13T02:55:06.493058Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":57,"content_modified":58},"NCT01145196","Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene",[],"2026-08-26T02:18:35.425468Z","2026-07-05T05:32:16.769994Z",{"nct_id":60,"title":61,"phases":62,"status":64,"updated_at":65,"content_modified":66},"NCT02402660","Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease",[63],"Phase 2","ENROLLING_BY_INVITATION","2026-08-26T02:17:46.653867Z","2026-06-16T05:54:07.952000Z",{"nct_id":68,"title":69,"phases":70,"status":71,"updated_at":72,"content_modified":73},"NCT04545736","Oral Metformin for Treatment of ABCA4 Retinopathy",[12],"ACTIVE_NOT_RECRUITING","2026-08-03T03:54:23.387833Z","2026-05-05T02:43:29.475371Z",{"nct_id":75,"title":76,"phases":77,"status":71,"updated_at":78,"content_modified":79},"NCT06591806","An Observational Study in Children and Adults With Stargardt Disease",[],"2026-08-03T02:06:20.225302Z","2026-05-13T02:55:06.552080Z"]